Vertex announces UK approval for CASGEVY™
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read Details
Media – Mode Shifting Dos, Don’ts and Benefits
Media – Mode Shifting Dos, Don’ts and Benefits
Mode Shifting Dos, Don’ts and Benefits
Gary Hutchinson
By Gail Dutton
World Trade WT-100
February 1, 2013
Stay on top of the industry trends
You may also like
Melinta Therapeutics announces FDA approval of REZZAYO™
Congratulations to Melinta Therapeutics for their FDA Approval of REZZAYO™ for the Treatment of...
read Details
Iveric Bio announces FDA approval for IZERVAY™️️
Congratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read Details